Bombardier on the Brink: Will Canada's F-35 Gamble Trigger U.S. Retaliation?

GuruFocus.com
03-19

Bombardier (BDRBF) is walking a tightrope as Canada reconsiders its $19 billion deal for 88 F-35 fighter jets from Lockheed Martin (NYSE:LMT). CEO Eric Martel isn't mincing wordshe's worried that if Canada pulls back, Washington could hit back by targeting Bombardier's U.S. defense contracts. That's a serious risk, given that 60% of the company's revenue flows from the U.S. With President Trump doubling down on tariffs, including fresh 25% duties on Canadian steel and aluminum, Bombardier is caught in the crossfire. The company has deferred providing its financial guidance for the year, citing trade war uncertainty.

  • Warning! GuruFocus has detected 2 Warning Sign with BDRBF.

The bigger problem? Bombardier's entire supply chain is deeply tied to the U.S. The flagship Global 7500 jet depends on American-made avionics, engines, and wingscomponents that could suddenly become a lot more expensive if new tariffs land. Meanwhile, Canada's new prime minister, Mark Carney, isn't backing down. His government is reassessing the F-35 contract to ensure it's in the country's best interest, but if it leads to broader trade retaliation, Bombardier could take a hit. With two-thirds of Canada's aerospace exports reliant on the U.S., any disruption could send shockwaves through the industry.

Despite the uncertainty, Martel is playing it smart. If U.S. tariffs bite, Bombardier could shift focus to non-U.S. customers, a move European rival Airbus (EADSY) has pulled off before. He also isn't convinced tariffs on its jets will stick. Still, investors aren't waiting aroundBombardier's stock has already dropped 18% since Trump's re-election. With the F-35 review still in play and trade tensions escalating, the stakes for Bombardier (and its investors) are massive.

This article first appeared on GuruFocus.

免责声明:投资有风险,本文并非投资建议,以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请,作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考,不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证,投资者应自行研究并在投资前寻求专业建议。

热议股票

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10